| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78edf11c335158eb6fbbc16bc36963bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71b851fcfcfed571131f652672e81e9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1263fc7b109d0f95b55878ed97ed0402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8b7db5ffc3055282776febb22d3aa7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_029fd0bd879a6852fe98ab611473e379
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f84747e8d08b1023763356d0e7d1db68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eeb763221f3a63cf54c8a6605ab1710f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06 |
| filingDate |
1996-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dc2bf4d8418619427eb21cf31797544
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d3f83dcb6c4110d34ef57b504b96878
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6e43be3179c69135f60fb97aa0bb532
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_059aa2bd8526038335187d3d715dbc7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44ebfd336d14826d1d7117c92b82324b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d4ed61423df6313a4c78945861c356d |
| publicationDate |
1996-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9631227-A1 |
| titleOfInvention |
Phosphonates, biphosphonates and pharmaceutical compositions containing them |
| abstract |
There are provided novel derivatives of certain phosphonates and bisphosphonates, and especially of compounds of the pamidronate and alendronate type. More particularly, the invention relates to aminoacyl and peptidyl derivatives of such compounds. Furthermore, the invention relates to pharmaceutical compositions which contain as active ingredient an adequate quantity of such novel compounds. The novel pharmaceutical compositions are characterized by improved absorption in the human body after application by the oral route. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022159492-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7071173-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6974802-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6432931-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6458772-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6699850-B2 |
| priorityDate |
1995-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |